FDA Approval of DS-8201

Quote

anonymous

Guest
Well, Daiichi-Sankyo received approval from the FDA today for DS-8201. If you haven’t heard about Daiichi-Sankyo Cancer Enterprise, you are about to hear a great deal about this company in the next decade.
 
















































anonymous said:
Any information on sales force hiring for this division? Thanks!
Click to expand...

good luck if you’re an Injectafer Rep. 8201 is GREAT for DSI, but means very little to 95% of the Injectafer sales force. If you’re not in the Good Ol Boy or The new “Good Ol Girl“ network just hold tight and don’t waste your time thinking you’ll get a face to face for an oncology opening.
.
 






anonymous said:
good luck if you’re an Injectafer Rep. 8201 is GREAT for DSI, but means very little to 95% of the Injectafer sales force. If you’re not in the Good Ol Boy or The new “Good Ol Girl“ network just hold tight and don’t waste your time thinking you’ll get a face to face for an oncology opening.
.
Click to expand...

just the next of many failures, small number of patients and we already have problems making it not to mention multiple lawsuits
 












anonymous said:
Ahh yes, I wondered when the Genentech crowd would start trying to sabotage our board.
Click to expand...

You’re funny, you think an Oncology powerhouse is worried about us? Past is prologue and failure is inevitable. Problem one, we’ve never sold here, problem two, were struggling like hell to make it, problem three, third line business is almost non-existent, problem four, we fail. Always. Go outside and look for a clue
 






anonymous said:
You’re funny, you think an Oncology powerhouse is worried about us? Past is prologue and failure is inevitable. Problem one, we’ve never sold here, problem two, were struggling like hell to make it, problem three, third line business is almost non-existent, problem four, we fail. Always. Go outside and look for a clue
Click to expand...
Wow, Negative Nelly aren’t we? Genentech is terrified. They have an incredibly weak pipeline and have a huge staff turnover since nobody wants to live in feces-laden San Francisco. Pertuzumab and T-DM1 will no longer have a place in treatment except in veterinary market. Generic trastuzumab is killing Herceptin. They have nothing. Three approvals in one year for a newbie in oncology. AZ is a powerhouse and great to have in our corner. Maybe you should leave Genentech now before the layoffs start.
 






anonymous said:
Wow, Negative Nelly aren’t we? Genentech is terrified. They have an incredibly weak pipeline and have a huge staff turnover since nobody wants to live in feces-laden San Francisco. Pertuzumab and T-DM1 will no longer have a place in treatment except in veterinary market. Generic trastuzumab is killing Herceptin. They have nothing. Three approvals in one year for a newbie in oncology. AZ is a powerhouse and great to have in our corner. Maybe you should leave Genentech now before the layoffs start.
Click to expand...

you’re a complete imbecile, they’ve sold billions we’ve sold zero. cross the finish line then think about celebrating loser
 












anonymous said:
you’re a complete imbecile, they’ve sold billions we’ve sold zero. cross the finish line then think about celebrating loser
Click to expand...

no , you are delusional. It’s not good news . ... very very small amount of patients for 8201 with current indication. Way way over staffed ! They only need 35-45 reps tops at major cancer institutions and academic centers . Zero community oncology business !
 






We all know we will get crushed. Marketing team keeps blowing us up, I get it but we haven’t sold a thing in ONC. Our sales leaders suck and our track record is really lousy. Those are facts. Pure and simple. Sorry Keith
 






anonymous said:
Fired recently from Daiichi-Sankyo? Or about to get fired from Genentech?
Click to expand...

so our President was fired from Amgen and so was our sales leader who never worked in oncology. I ain’t making that up go talk to any Amgen person and they’ll tell you both things are true. But yeah, sure, we‘’ll win. Makes tons of sense. Keep believing Peter Pan!!!!!
 






anonymous said:
so our President was fired from Amgen and so was our sales leader who never worked in oncology. I ain’t making that up go talk to any Amgen person and they’ll tell you both things are true. But yeah, sure, we‘’ll win. Makes tons of sense. Keep believing Peter Pan!!!!!
Click to expand...

Sadly this is largely true. Keller was let go for taking kickbacks from ION, he was gone in a day after 23 years. KW was an average DM, became an RD for about two months and was fired for harassing his reports. He was a modest producer and a real problem at Amgen and one day he just disappeared. Ask him, I dare you. Any Amgen employee will tell you this is true. We were sad to see Ken leave and happy to get rid of Woolley.

We’re doomed to fail, our leaders are unethical and dishonest. Not a very encouraging future despite all of KWs posts. Although could be his daughter or wife. They’re here A LOT.
 






anonymous said:
so our President was fired from Amgen and so was our sales leader who never worked in oncology. I ain’t making that up go talk to any Amgen person and they’ll tell you both things are true. But yeah, sure, we‘’ll win. Makes tons of sense. Keep believing Peter Pan!!!!!
Click to expand...

Yeah well we suck what should we say? We keep promising people stuff that isn’t true but they’re dumb enough to buy it from KK, DS and KW. So we can keep pretending and when we miss our number in Q1 we can just blame the home office on messing stuff up. I’m not gonna make excuses. I don’t know how to sell in oncology, they’ve done nothing to help me and Troy is as queer as a three dollar bill!!!
 






Top Bottom
Back
Quote